Boyer P J, Fahey J L
J Immunol. 1976 Jan;116(1):202-9.
Lymphoid cells from normal and immunized BALB/c mice could be stimulated in vitro by syngeneic PCT contrasted with an absence of response to a number of other tumors. Maximal responses of normal cells to PCT were found to occur 5 days after the initiation of the cultures at an optimal responding:stimulation cell ratio of 1:2. MLTI activity of normal cells could not be blocked or enhanced by PCT myeloma protein products indicating that MLTI reactivity was directed against non-idiotypec cell surface determinants. Lymphoid cells from immunized mice demonstrated increased MLTI responses to cells of the immunizing tumor but not to other PCT, indicating that the post-immunization MLTI responses were primarily to individual rather than shared tumor cell surface antigens. Activity of both normal and immunized spleen cells was found to involve thymus-derived lymphocytes. The persistence of residual MLTI activity after treatment with anti-theta serum and complement, however, implicated participation of non-theta antigen-bearing cells in MLTI reactivity. From these data, we conclude that lymphoid cells from un-immunized mice are capable of T cell-dependent reactivity to syngeneic PCT-associated antigens and that elevations in these reactivities after immunization may reflect specific cellular immune responses.
与对许多其他肿瘤无反应形成对比的是,来自正常和免疫的BALB/c小鼠的淋巴细胞在体外可被同基因的PCT刺激。发现正常细胞对PCT的最大反应在培养开始5天后出现,最佳反应:刺激细胞比例为1:2。PCT骨髓瘤蛋白产物不能阻断或增强正常细胞的MLTI活性,这表明MLTI反应性针对的是非独特型细胞表面决定簇。来自免疫小鼠的淋巴细胞对免疫肿瘤细胞的MLTI反应增强,但对其他PCT无增强,这表明免疫后的MLTI反应主要针对个体而非共同的肿瘤细胞表面抗原。发现正常和免疫脾细胞的活性都涉及胸腺来源的淋巴细胞。然而,用抗θ血清和补体处理后残余MLTI活性的持续存在,意味着非θ抗原-bearing细胞参与了MLTI反应性。从这些数据中,我们得出结论,未免疫小鼠的淋巴细胞能够对同基因PCT相关抗原产生T细胞依赖性反应,并且免疫后这些反应性的升高可能反映了特异性细胞免疫反应。